Who Exports Posaconazole from India — 51 Suppliers Behind a $115.1M Market
India's posaconazole export market is supplied by 51 active exporters who collectively shipped $115.1M across 274 shipments. AET LABORATORIES PRIVATE LIMITED leads with a 91.9% market share, followed by HETERO LABS LIMITED and GLAND PHARMA LTD. The top 5 suppliers together control 96.0% of total export value, reflecting a concentrated market structure.
Top Posaconazole Exporters from India — Ranked by Export Value
AET LABORATORIES PRIVATE LIMITED is the leading posaconazole exporter from India, holding a 91.9% share of the $115.1M market across 274 shipments from 51 exporters. The top 5 suppliers — AET LABORATORIES PRIVATE LIMITED, HETERO LABS LIMITED, GLAND PHARMA LTD, MSN LABORATORIES PRIVATE LIMITED, RESCUERS LIFE SCIENCES LIMITED — collectively control 96.0% of total export value, indicating a highly concentrated market. Individual shares are: AET LABORATORIES PRIVATE LIMITED (91.9%), HETERO LABS LIMITED (3.2%), GLAND PHARMA LTD (0.6%), MSN LABORATORIES PRIVATE LIMITED (0.3%), RESCUERS LIFE SCIENCES LIMITED (0.1%).
Top Posaconazole Exporters from India
Ranked by export value · 51 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | AET LABORATORIES PRIVATE LIMITED PHARMA : POSACONAZOLE DELAYED RELEASE TAPOSACONAZOLE 100MG GR TABLETS.POSACONAZOLE DELAYED RELEASE TABLETS 100 | $105.7M | 9 | 91.9% |
| 2 | HETERO LABS LIMITED PHARMA : POSACONAZOLE DELAYED RELEASE TAPOSACONAZOLE DELAYED RELEASE TABLETS 100POSACONAZOLE 100MG GASTRO-RESISTANT TABL | $3.7M | 6 | 3.2% |
| 3 | GLAND PHARMA LTD PHARMA : POSACONAZOLE DELAYED RELEASE TAPOSACONAZOLE DELAYED RELEASE TABLETS 100 | $720.7K | 1 | 0.6% |
| 4 | MSN LABORATORIES PRIVATE LIMITED PHARMA : POSACONAZOLE DELAYED RELEASE TAPOSACONAZOLE DELAYED RELEASE TABLETS 100 | $307.2K | 3 | 0.3% |
| 5 | RESCUERS LIFE SCIENCES LIMITED POSACONAZOLE GASTRO-RESISTANT TABLET 100WORKING ATAND POSACONAZOLE GASTRO-RESISTANT TAB 1000MG | $74.5K | 1 | 0.1% |
| 6 | PROGNOGEN GLOBAL HEALTHCARE PRIVATE LIMITED POSACONAZOLE 100MG GR TABLETS,POSACONAZOLE 100MG GASTRO-RESISTANT TABLETSPOSACONAZOLE 100MG GASTRO RESISTANT TABLETS, | $26.2K | 1 | 0.0% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Posaconazole exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| HETERO LABS LIMITED | Warning Letter, August 20 | Yes, as of 2018 | No | Not verified | Received FDA warning letter in August 2017 for Unit V; WHO-GMP certified as of 2 |
| GLAND PHARMA LTD | Approved | Yes, as of 2018 | No | Not verified | FDA-approved; WHO-GMP certified as of 2018. |
| MSN LABORATORIES PRIVATE LIMITED | Approved | Yes, as of 2018 | No | Not verified | FDA-approved; WHO-GMP certified as of 2018. |
TransData Nexus reviewed the regulatory standing of 3 leading Posaconazole exporters from India. 2 hold US FDA facility approvals, 3 maintain WHO-GMP certification, and 0 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Posaconazole sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as India's "Bulk Drug Capital," is a pivotal hub for active pharmaceutical ingredient (API) manufacturing. The city's industrial zones, including Balanagar, Bollaram, and Pashamylaram, host numerous API producers. Notably, Bio-Synth, a WHO-GMP–certified manufacturer located in Hyderabad's Balanagar Industrial Area, supplies high-purity Posaconazole API with comprehensive regulatory documentation for regulated markets. This concentration of API manufacturers underscores Hyderabad's critical role in the initial stages of the pharmaceutical supply chain.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. Companies such as Taj Pharma, based in Vapi, Gujarat, specialize in the production and export of Posaconazole gastro-resistant tablets. Taj Pharma's WHO-GMP–certified facilities ensure that their antifungal formulations meet stringent quality standards, catering to both domestic and international markets. This region's focus on finished dosage forms complements the API production strengths of other clusters.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a strategic export gateway for pharmaceutical products. Proximity to major ports facilitates efficient international distribution. Companies like Beta Chemical Co., located in Mumbai, offer active pharmaceutical ingredients, including Posaconazole, leveraging the region's logistical advantages to serve global markets. This logistical infrastructure is vital for the timely and cost-effective export of pharmaceutical products.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, situated in Himachal Pradesh, has emerged as a significant pharmaceutical manufacturing hub, partly due to favorable tax incentives. The region hosts numerous pharmaceutical companies, contributing substantially to India's pharmaceutical output. However, specific data on Posaconazole production in this cluster is limited.
5Sourcing Recommendations
- Diversify Supplier Base: While AET Laboratories Private Limited dominates Posaconazole exports, accounting for 91.9% of the total value, engaging with other suppliers such as Hetero Labs Limited and Gland Pharma Ltd can mitigate supply chain risks.
- Leverage Regional Strengths: Utilize Hyderabad's API manufacturing capabilities for sourcing raw materials and Gujarat's formulations expertise for finished products to optimize the supply chain.
- Assess Logistical Efficiency: Consider the Mumbai-Thane-Raigad region for export operations to benefit from superior logistics and port facilities, ensuring timely delivery to international markets.
- Monitor Regulatory Compliance: Ensure that all suppliers adhere to international quality standards, such as WHO-GMP certification, to maintain product integrity and facilitate market access.
By strategically engaging with these regional clusters and suppliers, companies can enhance the resilience and efficiency of their Posaconazole supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Posaconazole exporters from India
MSN Laboratories Private Limited — MSN Laboratories receives Mexican approval for Bortezomib solution
The Comisión de Autorización Sanitaria granted MSN Laboratories Private Limited a sanitary registration for Bortezomib solution, valid until February 17, 2028. (gob.mx) - IMPACT: This approval may enhance MSN Laboratories' market presence in Mexico, potentially influencing their Posaconazole export strategies.
Impact: This approval may enhance MSN Laboratories' market presence in Mexico, potentially influencing their Posaconazole export strategies.
Hetero Labs Limited — Hetero Labs secures Mexican approval for Azacitidine suspension
The Comisión de Autorización Sanitaria granted Hetero Labs Limited a sanitary registration for Azacitidine suspension, valid until February 17, 2028. (gob.mx) - IMPACT: This approval may strengthen Hetero Labs' product portfolio in Mexico, potentially affecting their Posaconazole export focus.
Impact: This approval may strengthen Hetero Labs' product portfolio in Mexico, potentially affecting their Posaconazole export focus.
MSN Laboratories Private Limited — MSN Laboratories obtains Mexican approval for Atorvastatin tablets
The Comisión de Autorización Sanitaria granted MSN Laboratories Private Limited a sanitary registration for Atorvastatin tablets, valid until February 17, 2028. (gob.mx) - IMPACT: This approval may expand MSN Laboratories' product offerings in Mexico, potentially influencing their Posaconazole export dynamics.
Impact: This approval may expand MSN Laboratories' product offerings in Mexico, potentially influencing their Posaconazole export dynamics.
Common Questions — Posaconazole Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which posaconazole supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, AET LABORATORIES PRIVATE LIMITED leads with 121 recorded shipments worth $105.7M. HETERO LABS LIMITED (30 shipments) and GLAND PHARMA LTD (6 shipments) are also established high-volume exporters.
Q How many posaconazole manufacturers are there in India?
India has 51 active posaconazole exporters with a combined export market of $115.1M across 274 shipments to 41 countries. The top 5 suppliers hold 96.0% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for posaconazole from India?
Average FOB unit price: $64.82 per unit, ranging from $0.01 to $7069.86. Average shipment value: $419.9K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 51 verified Indian exporters of Posaconazole ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 274 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 41 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
274 Verified Shipments
51 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists